SIGLEC1 and autoimmune disease: Previous studies have shown that the frequency of CD169+ monocytes is associated with the disease activity in autoimmune diseases, such as systemic sclerosis [23], systemic lupus erythematosus [24] and rheumatoid arthritis [25].